Hirschsprung's disease
A congenital condition affecting the colon
Overview
Hirschsprung's disease is a congenital condition characterized by the absence of ganglion cells in the colon, leading to severe constipation or intestinal obstruction. This condition is also known as congenital aganglionic megacolon. It is named after the Danish physician Harald Hirschsprung, who first described the condition in 1888.
Pathophysiology
In Hirschsprung's disease, the absence of ganglion cells occurs in the myenteric plexus and submucosal plexus of the bowel. This results in a lack of peristalsis in the affected segment, causing a functional obstruction. The proximal bowel becomes dilated due to the accumulation of fecal material, leading to the characteristic megacolon.
Clinical Presentation
The disease typically presents in newborns with symptoms such as failure to pass meconium within the first 48 hours of life, abdominal distension, and vomiting. In older children, it may present as chronic constipation, failure to thrive, and enterocolitis.
Diagnosis
Diagnosis is confirmed through a combination of clinical evaluation, radiological imaging, and histopathological examination. A barium enema may show a transition zone between the normal and affected bowel. A definitive diagnosis is made by a rectal biopsy demonstrating the absence of ganglion cells.
Treatment
The primary treatment for Hirschsprung's disease is surgical. The most common procedure is the pull-through surgery, where the aganglionic segment is resected, and the normal bowel is anastomosed to the anus.
Prognosis
With appropriate surgical intervention, most children with Hirschsprung's disease can lead normal lives. However, some may experience complications such as enterocolitis, fecal incontinence, or constipation post-surgery.
Related pages
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian